Strauss David P 4

Accession 0001707925-25-000019

CIK 0001707925other

View on SEC.gov Company Profile

Filed

Mar 3, 7:00 PM ET

Accepted

Mar 4, 3:01 PM ET

Size

25.9 KB

Accession

0001707925-25-000019

Insider Transaction Report

Form 4

Period: 2025-03-03

LINDE PLCLIN

Strauss David P

Executive VP, Chief HR Officer

Transactions

Exercise/Conversion
Ordinary Shares
2025-03-03$154.00/sh+7,545$1,161,930→ 8,844.897 total
Sale
Ordinary Shares
2025-03-03$469.74/sh−2,477$1,163,546→ 1,299.897 total
Exercise/Conversion
Stock Options (right to buy)
2025-03-03−7,545→ 7,545 total
Exercise: $154.00Exp: 2028-02-27→ Ordinary Shares (7,545 underlying)
Tax Payment
Ordinary Shares
2025-03-03$469.95/sh−5,068$2,381,707→ 3,776.897 total

Holdings

Stock Options (right to buy)
Exercise: $465.29From: 2025-03-07Exp: 2034-03-07→ Ordinary Shares (8,010 underlying)
8,010
Ordinary Shares
(indirect: By Trust)
24,626.2
Ordinary Shares
(indirect: By 401(k))
1,946.055
Restricted Stock Units
→ Ordinary Shares (1,235 underlying)
1,235
Restricted Stock Units
→ Ordinary Shares (1,290 underlying)
1,290
Restricted Stock Units
→ Ordinary Shares (1,180 underlying)
1,180
Stock Options (right to buy)
Exercise: $354.14From: 2024-03-07Exp: 2033-03-07→ Ordinary Shares (8,515 underlying)
8,515
Stock Options (right to buy)
Exercise: $253.68From: 2022-03-08Exp: 2031-03-08→ Ordinary Shares (15,925 underlying)
15,925
Stock Options (right to buy)
Exercise: $176.63From: 2020-03-20Exp: 2029-03-20→ Ordinary Shares (20,985 underlying)
20,985
Stock Options (right to buy)
Exercise: $270.99From: 2023-03-07Exp: 2032-03-07→ Ordinary Shares (10,200 underlying)
10,200
Stock Options (right to buy)
Exercise: $173.13Exp: 2030-03-09→ Ordinary Shares (20,870 underlying)
20,870
Deferred Stock Units
→ Ordinary Shares (236.828 underlying)
239.778

Footnotes (15)

[F1]Ordinary shares withheld to cover exercise price and tax withholdings.
[F10]This option vests over three years in three consecutive equal annual installments beginning on March 8, 2022.
[F11]This option vests over three years in three consecutive equal annual installments beginning on March 9, 2021.
[F12]This option vests over three years in three consecutive equal annual installments beginning on March 20, 2020.
[F13]This option vested in full three years after the grant date.
[F14]Conversion to Linde plc Ordinary Shares is on a one-to-one basis.
[F15]Deferred stock units acquired under the Linde Compensation Deferral Plan as amended ("Plan"). The deferred stock units will payout in Linde plc Ordinary Shares on a one-for-one basis in accordance with the Plan.
[F2]The price reported is the weighted average sale price. The sale prices ranged from $469.72 to $469.95. Upon request of the SEC Staff, Linde plc or a security holder of the issuer, the reporting person will provide full information regarding the number of shares sold at each separate price.
[F3]Restricted Stock Units that will vest in full and payout on or about March 7, 2027 in Linde plc Ordinary Shares on a one-for-one basis.
[F4]Restricted Stock Units that will vest in full and payout on or about March 7, 2026 in Linde plc Ordinary Shares on a one-for-one basis.
[F5]Restricted Stock Units that will vest in full and payout on or about March 7, 2025 in Linde plc Ordinary Shares on a one-for-one basis.
[F6]Restricted Stock Units that will vest in full and payout on or about March 8, 2024 in Linde plc Ordinary Shares on a one-for-one basis.
[F7]This option vests over three years in three consecutive equal annual installments beginning on March 7, 2025.
[F8]This option vests over three years in three consecutive equal annual installments beginning on March 7, 2024.
[F9]This option vests over three years in three consecutive equal annual installments beginning on March 7, 2023.

Documents

1 file

4
wk-form4_1741118452.xmlPrimary
FORM 4

Issuer

LINDE PLC

CIK 0001707925

→

Entity typeother

Related Parties

filerCIK 0001705851

Filing Metadata

Form type: 4
Filed: Mar 3, 7:00 PM ET
Accepted: Mar 4, 3:01 PM ET
Size: 25.9 KB

View on SEC.gov